Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

Market Cap	661.51M -21.5%
Revenue (ttm)	438.66M -4.1%
Net Income	-32.99M
EPS	-0.02
Shares Out	2.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	325,000
Average Volume	1,801,750
Open	0.3100
Previous Close	0.3100
Day's Range	0.3000 - 0.3100
52-Week Range	0.2700 - 0.6500
Beta	-0.06
RSI	45.20
Earnings Date	Mar 27, 2026

About HKG:8189

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People’s Republic of China. It operates through two segments: Fertiliser Products, and Elderly Care and Health Care Services. The company’s biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas that are used for the facilitation of balanced growth of grains, fruits, and ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2000
• Employees: 260
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8189

Financial Performance

In 2024, HKG:8189's revenue was 385.48 million, a decrease of -3.14% compared to the previous year's 398.00 million. Losses were -27.80 million, 37.9% more than in 2023.

Financial numbers in CNY